Kane Biotech Q3 EPS $(0.01) Up From $(0.012) YoY, Sales $286.838K Up From $126.559K YoY

Kane Biotech (TSXV:KNE) reported quarterly losses of $(0.01) per share. This is a 16.67 percent increase over losses of $(0.012) per share from the same period last year. The company reported $286.838 thousand in sales

Benzinga · 11/14/2019 21:31

Kane Biotech (TSXV:KNE) reported quarterly losses of $(0.01) per share. This is a 16.67 percent increase over losses of $(0.012) per share from the same period last year. The company reported $286.838 thousand in sales this quarter. This is a 126.64 percent increase over sales of $126.559 thousand the same period last year.